Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Common Equity (2016 - 2026)

SANUWAVE Health has reported Common Equity over the past 17 years, most recently at $1.8 million for Q1 2026.

  • Quarterly Common Equity rose 108.83% to $1.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Mar 2026, up 108.83% year-over-year, with the annual reading at $1.6 million for FY2025, 110.25% up from the prior year.
  • Common Equity was $1.8 million for Q1 2026 at SANUWAVE Health, up from $1.6 million in the prior quarter.
  • Over five years, Common Equity peaked at $1.8 million in Q1 2026 and troughed at -$66.0 million in Q3 2023.
  • The 5-year median for Common Equity is -$38.1 million (2022), against an average of -$34.2 million.
  • Year-over-year, Common Equity crashed 128.86% in 2022 and then surged 110.25% in 2025.
  • A 5-year view of Common Equity shows it stood at -$41.0 million in 2022, then fell by 8.62% to -$44.5 million in 2023, then surged by 64.54% to -$15.8 million in 2024, then surged by 110.25% to $1.6 million in 2025, then rose by 13.53% to $1.8 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Common Equity are $1.8 million (Q1 2026), $1.6 million (Q4 2025), and -$7.6 million (Q3 2025).